ArticleLangenbeck's archives of surgery2006

Targeting the EGF/VEGF-R system by tyrosine-kinase inhibitors--a novel antiproliferative/antiangiogenic strategy in thyroid cancer.

S Hoffmann et al.PubMed ↗Publisher ↗

No numbers read from the abstract.